Develops systems to reduce blood-borne pathogens in donated blood components.
Dec 2025Revenue $234M/yrExpenses $242M/yr
No trendCash runway over 10 years from Jun 2026
Figures by year
When will Cerus be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $234M and expenses $242M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $234M | $242M | −$8.68M |
| Dec 2024 | $201M | $216M | −$14.2M |
| Dec 2023 | $187M | $217M | −$30.1M |
| Dec 2022 | $188M | $222M | −$34.1M |
| Dec 2021 | $160M | $208M | −$48.9M |
| Dec 2020 | $114M | $173M | −$58.3M |
| Dec 2019 | $93.8M | $160M | −$66.2M |
| Dec 2018 | $76.1M | $131M | −$55.0M |
| Dec 2017 | $51.3M | $109M | −$57.5M |
| Dec 2016 | $39.3M | $101M | −$61.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.